The Patent Finder

Seikagaku Corporation

66 patents currently held · Updated Nov 22, 2026
2 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 3 name spellings.

10
Ending by 2030
Jun 2027
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 2 fees due Jan 16 to 28, 2027 · next Jan 16
  • 1 fee due Feb 28, 2027
    The maintenance fee for Composition for Treating Joint Disease and Kit Containing Same (US 11,738,040) comes due Feb 28, 2027. Unpaid by Aug 30, 2027, it lapses early.
  • 3 fees due Mar 5 to 24, 2027 · next Mar 5
  • 1 fee due Apr 10, 2027
    The maintenance fee for Agent for improving ocular subjective symptoms and method thereof (US 11,779,593) comes due Apr 10, 2027. Unpaid by Oct 12, 2027, it lapses early.
  • 2 fees due Oct 2 to 16, 2027 · next Oct 2

Which patents, and when each one lapses · Pro

Recent changes

  • 2 of the patents on this record were granted since Aug 24, 2026
  • 1 term has ended since Aug 24, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,927,837Modified chondroitin synthase polypeptide and crystal thereof
In force
 · USPTO record
In forceUSPTO record
US 9,301,972Hyaluronic acid derivatives
In force
 · USPTO record
In forceUSPTO record
US 9,616,087Pharmaceutical agent having long-lasting effect of treating arthritic disorders
In force
 · USPTO record
In forceUSPTO record
US 8,283,145Chondroitin-producing bacterium and method of producing chondroitin
In force
 · USPTO record
In forceUSPTO record
US 8,889,652Pharmaceutical agent having long-lasting effect of treating arthritic disorders
In force
 · USPTO record
In forceUSPTO record
US 8,557,986Method of producing polysaccharide derivatives
In force
 · USPTO record
In forceUSPTO record
US 8,529,519Tight-sealing cap for liquid drug-expelling part
In force
 · USPTO record
In forceUSPTO record
US 10,420,795Pharmaceutical composition for relieving pain
In force
 · USPTO record
In forceUSPTO record
US 9,579,342Pharmaceutical composition for relieving pain
In force
 · USPTO record
In forceUSPTO record
US 8,828,969Pharmaceutical composition for relieving pain
In force
 · USPTO record
In forceUSPTO record
10 of 66 patents shown.
Pro members see all 66.
Pro members: see all 66 patents
Also on record, not counted in the 66: 2 patents in force now held by others · 84 lapsed for an unpaid fee · 73 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

4 pending · 15 abandoned · 45 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited